arGEN-X BV (argen)

Oncology Corporate Profile

HQ Location

Willemstraat 5, 4811 AH Breda
4811 AH Breda, The Netherlands

Company Description

arGEN-X is a clinical stage human therapeutic antibody company that is rapidly developing a product pipeline using its unique suite of antibody technologies. arGEN-X is creating first and best in class antibody therapeutics with highly differentiated target product profiles. Its therapeutic antibody programs, focused on cancer and autoimmune indications, are designed to deliver tangible benefits to patients with these diseases.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
argx-110anti-CD70 monoclonal antibody (humanized)Various cancer typesI
argx-111mAb against c-Met inhibitorVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display